第9章 產品研發線

第10章 全球白蛋白市場

第11章 市場情況

第12章 各用途市場市場區隔

第13章 各地區市場區隔

第14章 中國的白蛋白市場

第15章 推動市場的要素

第16章 促進要素的影響

第17章 市場課題

第18章 促進要素與課題的影響

第19章 市場趨勢

第20章 供應商環境

競爭模式

市場佔有率分析:2015年

CSL Behring

Grifols

Baxalta

Octapharma

Kedrion

其他值得注意的供應商

第21章 附錄

第22章 關於Technavio

目錄

Product Code: IRTNTR9576

About the Human Albumin Market

Albumin-based therapies such as Idelvion (CSL654 rIX-FP) by CSL Behring received marketing approval from the US FDA in March 2016 and from the EMA in May 2016. Apart from these, Albutropin (TV-1106) by Teva Pharmaceuticals, Ampion by Ampio Pharmaceuticals, and Albutein by Grifols (for Alzheimer's disease) are expected to enter the market during the forecast period.

The demand for albumin is high in APAC in countries like India and China. Still, the uptake of these therapeutics is less due to the lack of awareness about these products and their therapeutic uses. Thus, the awareness programs conducted by organizations such as PPTA, which includes International Plasma Awareness Week, to help increase the awareness about plasma donation and the different plasma protein therapies available, along with their potential uses, is expected to increase the uptake of these therapeutics in treating various conditions.

Technavio's analysts forecast the global human albumin market to grow at a CAGR of 4.97% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global human albumin market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded and generic albumin drugs used to treat infections, liver diseases, shock, during surgery, and severe burns. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched in the market along with the decline in revenues from the genericization of the marketed drugs during the forecast period.

The market is divided into the following segments based on geography:

Americas

APAC

EMEA

Technavio's report, Global Human Albumin Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

CSL Behring

Grifols

Baxalta

Octapharma

Kedrion

Other Prominent Vendors

AADi

Ablynx

Albumedix

Ampio Pharmaceuticals

Azaya Therapeutics

Beijing Tiantan

Biotest

Bristol-Myers Squibb

Celgene

ConjuChem

GSK

Hebei Changshan Biochem Pharma

HiMedia Laboratories

Hualan Biological Engineering

InVittria

MedxBio

Merck

Mitsubishi Tanabe Pharma

NantBioScience

Novo Nordisk

Novozymes

Shanghai RAAS Blood Products

Sucampo Pharmaceuticals

Teva Pharmaceuticals

Thermo Fisher Scientific

Tianjin SinoBiotech & Beijing Bio-Fortune

Ventria Bioscience

Yoshitomi Pharmaceutical

Market driver

High demand for human albumin in China

For a full, detailed list, view our report

Market challenge

Spread of pathogenic contaminants

For a full, detailed list, view our report

Market trend

Rise in non-therapeutic applications

For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2020 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.